Revefenacin, sold under the brand name Yupelri, is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is inhaled once daily to help relax airway muscles and improve breathing.
Parent: Revefenacin
Parent: Revefenacin
![1-(2-((2-(methylamino) ethyl)aminomethyl)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](https://veeprho.com/wp-content/uploads/2023/05/1-2-2-methylamino-ethyl-aminomethyl-ethyl-piperidin-4-yl-1-1-biphenyl-2-ylcarbamate.png "1-(2-((2-(methylamino) ethyl)aminomethyl)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate")
Parent: Revefenacin
![1-(2-((4-((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)(methyl)amino)ethyl) piperidin-4-yl [1,1'-biphenyl]-2-yl carbamate](https://veeprho.com/wp-content/uploads/2023/05/1-2-4-2-4-1-1-biphenyl-2-ylcarbamoyl-oxy-piperidin-1-yl-ethyl-methyl-carbamoyl-benzyl-methyl-amino-ethyl-20piperidin-4-yl-1-1-biphenyl-2-yl-carbamate.png "1-(2-((4-((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)(methyl)amino)ethyl) piperidin-4-yl [1,1'-biphenyl]-2-yl carbamate")
Parent: Revefenacin
![1-(2-(3-([1,1'-biphenyl]-2-yl)-1-methylureido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-yl carbamate](https://veeprho.com/wp-content/uploads/2023/05/1-2-3-1-1-biphenyl-2-yl-1-methylureido-ethyl-piperidin-4-yl-1-1-biphenyl-2-yl-carbamate.png "1-(2-(3-([1,1'-biphenyl]-2-yl)-1-methylureido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-yl carbamate")
Parent: Revefenacin
![1-(2-(N,4-dimethylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](https://veeprho.com/wp-content/uploads/2023/05/1-2-N-4-dimethylbenzamido-ethyl-piperidin-4-yl-1-1-biphenyl-2-ylcarbamate.png "1-(2-(N,4-dimethylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate")
Parent: Revefenacin
Parent: Revefenacin
![4-((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzoic acid](https://veeprho.com/wp-content/uploads/2023/05/4-2-4-1-1-biphenyl-2-ylcarbamoyl-oxy-piperidin-1-yl-ethyl-methyl-carbamoyl-benzoic-acid.png "4-((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzoic acid")
Parent: Revefenacin
Parent: Revefenacin
Impurities in Revefenacin can arise during manufacturing, storage, and formulation. These impurities must be identified and controlled to ensure drug safety and efficacy.
Analytical Techniques for Impurity Detection
Revefenacin is used for the long-term maintenance treatment of COPD. It relaxes airway muscles, making breathing easier for patients with chronic bronchitis or emphysema.
Revefenacin is a LAMA (Long-Acting Muscarinic Antagonist), which helps keep airways open for a prolonged period. It is not a LABA (Long-Acting Beta Agonist).
No, Yupelri (Revefenacin) and Albuterol are different. Albuterol is a short-acting beta agonist (SABA) used for quick relief of bronchospasms, while Yupelri is a long-acting maintenance treatment for COPD.
Both Yupelri (Revefenacin) and Spiriva (Tiotropium) are LAMA medications for COPD. However, Yupelri is a nebulized solution, while Spiriva is available as an inhaler (HandiHaler or Respimat).
